Class III
Ongoing
Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS,…
Why: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
- Company
- Ascend Laboratories, LLC
Bedminster, NJ, United States - Reported
- Aug 5, 2026
- Recall started
- Jul 16, 2026
- Where sold
- USA Nationwide
- Amount
- 924 cartons x 12 x 6 x 10 (in blister pack)
- Full product description
- Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68.
- Lots / codes affected
- Lot: 25141585, Exp. April 30, 2027.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.